Fairvalue-Calculator Fairvalue-Calculator
EN DE

LIWANLI Innovation Co (3054) Fair Value & Analysis

Healthcare · TW · Market cap 5.5B TWD

Price66.00 TWD
Fair Value18.17 TWD
Upside-72.5%
Quality95/100
Evidence: Medium Range 13.33 TWD – 38.64 TWD

Fair value as of: Jun 24, 2026

Analysis

LIWANLI Innovation Co (3054) currently trades at 66.00 TWD, while our model-based Fair Value estimate is 18.17 TWD — implying the stock looks roughly 72.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is headquartered in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is LIWANLI Innovation Co (3054) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18.17 TWD versus a price of 66.00 TWD — about −72% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 3054?
Our 21-model fair value for LIWANLI Innovation Co is 18.17 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 66.00 TWD.
What is the quality score of 3054?
LIWANLI Innovation Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.